hydroxyurea and misonidazole
hydroxyurea has been researched along with misonidazole in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bundy, BN; Creasman, WT; Currie, JL; Keys, H; Mortel, R; Stehman, FB | 1 |
Allen, J; Edwards, MS; Levin, VA; Ortega, J; Vestnys, P; Wara, WM | 1 |
Bundy, BN; Creasman, WT; d'Ablaing, G; Fowler, WC; Keys, HM; Mortel, R; Stehman, FB; Thomas, G | 1 |
Anderson, LL; Donohue, KA; Heller, PB; Hernandez, E; Stehman, FB | 1 |
Ali, S; Lanciano, R; Rose, PG; Stehman, FB; Whitney, CW | 1 |
Trials
3 trial(s) available for hydroxyurea and misonidazole
Article | Year |
---|---|
A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Hydroxyurea; Middle Aged; Misonidazole; Random Allocation; Uterine Cervical Neoplasms | 1988 |
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cause of Death; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Hydroxyurea; Life Tables; Middle Aged; Misonidazole; Recurrence; Survival Analysis; Uterine Cervical Neoplasms | 1993 |
The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Hydroxyurea; Incidence; Lymph Node Excision; Middle Aged; Misonidazole; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Survival Analysis; Thrombocytosis; Uterine Cervical Neoplasms | 2000 |
Other Studies
2 other study(ies) available for hydroxyurea and misonidazole
Article | Year |
---|---|
5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cobalt Radioisotopes; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Fluorouracil; Glioblastoma; Glioma; Humans; Hydroxyurea; Lomustine; Male; Misonidazole; Prognosis; Radioisotope Teletherapy | 1984 |
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Hydroxyurea; Middle Aged; Misonidazole; Neoplasm Staging; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |